301156.SZ
美农生物
SZSE · Consumer Defensive · C 制造业 · CN
CNY 11.43
−2.64%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 620.4M | 561.3M | 489.9M | 504.4M | 483.3M |
| Cost of Revenue | 426.5M | 389.3M | 348.8M | 353.4M | 343.0M |
| Gross Profit | 193.9M | 172.0M | 141.2M | 151.0M | 140.3M |
| Operating Expenses | |||||
| R&D Expense | 25.6M | 24.8M | 20.9M | 22.0M | 21.4M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 42.1M | 39.5M | 31.6M | 35.4M | 31.2M |
| Selling & Marketing Expense | 50.1M | 46.6M | 38.3M | 37.6M | 30.9M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 124.5M | 114.8M | 88.5M | 93.0M | 79.6M |
| Cost and Expenses | 551.0M | 504.1M | 437.3M | 446.5M | 422.5M |
| Operating Income (EBIT) | 65.3M | 60.6M | 54.5M | 66.7M | 58.5M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 65.3M | 60.8M | 55.8M | 70.2M | 58.3M |
| Income Tax Expense | 6.0M | 6.0M | 6.2M | 7.2M | 5.8M |
| Bottom Line | |||||
| Net Income | 59.4M | 54.8M | 49.6M | 63.0M | 52.5M |
| Earnings from Cont. Ops | 59.4M | 54.8M | 49.6M | 63.0M | 52.5M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 59.4M | 54.8M | 49.6M | 63.0M | 52.5M |
| Per Share | |||||
| Basic EPS | CN¥0.42 | CN¥0.39 | CN¥0.34 | CN¥0.43 | CN¥0.54 |
| Diluted EPS | CN¥0.42 | CN¥0.39 | CN¥0.34 | CN¥0.43 | CN¥0.54 |
| Revenue Per Share | CN¥4.41 | CN¥3.98 | CN¥3.40 | CN¥3.47 | CN¥4.93 |
| Shares | |||||
| Basic Shares Outstanding | 140.7M | 140.9M | 144.0M | 145.2M | 98.0M |
| Diluted Shares Outstanding | 140.7M | 140.9M | 144.0M | 145.2M | 98.0M |
| Profitability Metrics | |||||
| EBITDA | — | 90.2M | 79.3M | 87.2M | 69.5M |
| D&A | — | 29.6M | 24.8M | 20.5M | 11.0M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026